CSI Market
Sign In | Register

Precision Biosciences Inc (DTIL) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access DTIL Annual Cash Flow →
The data below summarizes Precision Biosciences Inc's cash flow activity from Jun 30 2025 to Jun 30 2026, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-51.09
Depreciation & amortization0.55
Amortization of Other Assets0.12
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business0.01
Share-based Compensation3.39
Income (Loss) from Equity Method Investments0.00
Increase (Decrease) in Marketable Securities, Restricted20.92
Gains Losses On Sales Of Assets0.00
Non Cash Interest Expense-
Change In Fair Value Of Convertible Notes Payable-
Increase Decrease In Accrued Other Expenses And Other Current Liabilities-1.80
Operating Lease Right Of Use Asset Amortization Expense0.34
Fair Value Option Changes In Fair Value Gain Loss2.95
Deconsolidation Gain Or Loss Amount-
Equity Securities Fv Ni Gain Loss-
Amortization Of Discount On Note Receivable-
Increase Decrease In Contract With Customer Asset-
Increase Decrease In Other Assets And Other Current Assets0.04
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.53
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.89
Other Working Capital0.00
Other Noncash Income0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.68
Discontinued operations0.00
Net Cash flow from Operating Activities-25.38
Investing Activities
Capital Expenditures-0.02
Sale of Capital Items0.01
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments To Purchase Intangible Assets-0.10
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-0.10
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.11
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.66
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.08
Proceeds From Employee Stock Purchase Plan0.08
Proceeds From Issuance Of Common Stock To Collaboration Partners-
Borrowings From Revolving Credit Facility-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents137.15
Noncash Or Part Noncash Acquisition Fixed Assets Acquired-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.75
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-25.39
Total Cash Flow-24.75
4 historic quarters locked

Sign in to unlock the full Precision Biosciences Inc cash flow history.

Sign In Create Free Account

About Precision Biosciences Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001628280-26-053837

Figures are derived from filed reports and may be restated. Historical data is subject to revision.